Vaucher E., Reymond I., Najaffe R., Kar S., Quirion R., Miller M. M., Franklin K. B. (2002). Estrogen effects on object memory and cholinergic receptors in young and old female mice, Neurobiol Aging, 23(1), 87-95.

Williams S., Souchelnytskyi S., Danik M. (2002). TGFbeta2 mediates rapid inhibition of calcium influx in identified cholinergic basal forebrain neurons, Biochem Biophys Res Commun, 290(4), 1321-7.

Wilner A. P., de Varennes B., Gregoire P. A., Lupien S., Pruessner J. (2002). Glucocorticoids and hippocampal atrophy after heart transplantation, Ann Thorac Surg, 73(6), 1965-7.

Zetterberg H., Palmer M., Ricksten A., Poirier J., Palmqvist L., Rymo L., Zafiropoulos A., Arvanitis D. A., Spandidos D. A., Blennow K. (2002). Influence of the apolipoprotein E epsilon4 allele on human embryonic development, Neurosci Lett, 324(3), 189-92.

Zheng W. H., Kar S., Quirion R. (2002). Insulin-like growth factor-1-induced phosphorylation of transcription factor FKHRL1 is mediated by phosphatidylinositol 3-kinase/Akt kinase and role of this pathway in insulin-like growth factor-1-induced survival of cultured hippocampal neurons, Mol Pharmacol, 62(2), 225-33.

Zheng W. H., Kar S., Quirion R. (2002). The forkhead family of transcription factors are targets of Akt in IGF-1 mediated survival in neuronal cells . Dans Mizuno Y., Fisher A., Hanin I. & Mizuno Y. (Éds.) , Mapping the progress of Alzheimer's and Parkinson's Disease (pp. 217-221). Kluwer Academic/Plenum Publishers.

Zheng W. H., Kar S., Quirion R. (2002). FKHRL1 and its homologs are new targets of nerve growth factor Trk receptor signaling, J Neurochem, 80(6), 1049-61.

de Leon M. J., Segal S., Tarshish C. Y., DeSanti S., Zinkowski R., Mehta P. D, Convit A., Caraos C., Rusinek H., Tsui W., Saint Louis L. A., DeBernardis J., Kerkman D., Qadri F., Gary A., Lesbre P., Wisniewski T., Poirier J., Davies P. (2002). Longitudinal cerebrospinal fluid tau load increases in mild cognitive impairment, Neurosci Lett , 333 (3 ), 183-186.

Auld D. S., Mennicken F., Day J. C., Quirion R. (2001). Neurotrophins differentially enhance acetylcholine release, acetylcholine content and choline acetyltransferase activity in basal forebrain neurons, J Neurochem, 77(1), 253-62.

Auld D. S., Mennicken F., Quirion R. (2001). Nerve growth factor rapidly induces prolonged acetylcholine release from cultured basal forebrain neurons: differentiation between neuromodulatory and neurotrophic influences, J Neurosci, 21(10), 3375-82.

, Quirion R. (2001). The protective abilities of ginkgo biloba extract (EGb 761) against amyloid-induced toxicity depend on its flavonoid constituents . Dans Christen Y. (Éd.) , Advances Ginkgo Biloba Extracts Research (pp. 91-106). Solal.

, Quirion R. (2001). Resveratol and red wine constituents: Evaluation of their neuroprotectice properties, Pharm News, 8, 1-6.

Cervantes P., Gelber S., Kin F. N., Nair N., Schwartz G. (2001). Circadian secretion of cortisol in bipolar disorder, J Psychiatry Neurosci, 26(5), 411-6.

Chertkow H., Bergman H., Schipper H. M., Gauthier S., Bouchard R., Fontaine S., Clarfield A. M. (2001). Assessment of suspected dementia, Can J Neurol Sci, 28 Suppl 1, S28-41.

Day J. C., Kornecook T. J., Quirion R. (2001). Application of in vivo microdialysis to the study of cholinergic systems, Methods, 23(1), 21-39.

Doré S., Quirion R. (2001). IGF-1, insulin, brain glucose, and cognition . Dans Craighead W. E. & Nemeroff C. B. (Éds.) , The Corsini Encyclopedia of Psychology and Behavioral Science (pp. 728-733). John Wiley & Sons, Inc..

Feldman H., Gauthier S., Hecker J., Vellas B., Subbiah P., Whalen E. (2001). A 24-week, randomized, double-blind study of donepezil in moderate to severe Alzheimer's disease, Neurology, 57(4), 613-20.

Feldman H., Sauter A., Donald A., Gelinas I., Gauthier S., Torfs K., Parys W., Mehnert A. (2001). The disability assessment for dementia scale: a 12-month study of functional ability in mild to moderate severity Alzheimer disease, Alzheimer Dis Assoc Disord, 15(2), 89-95.

Gauthier S. (2001). Muscarinic agonists . Dans Gauthier S. & Cummings J. L. (Éds.) , Alzheimer's Disease and Related Disorders Annual (pp. 85-96). Martin Dunitz Ltd..

Gauthier S. (2001). Alzheimer's disease: current and future therapeutic perspectives, Prog Neuropsychopharmacol Biol Psychiatry, 25(1), 73-89.